IRulya Therapeutics QNCX
NASDAQ QNCX
$40.27 +5.82 (+16.89%)
At close: Oct 20, 2026 · 4:00 PM EDT

Quince Therapeutics, Inc. (QNCX) Change in Other Operating Liabilities (2025 - 2026)

Updated

IRulya Therapeutics (QNCX) recorded Change in Other Operating Liabilities of -$688,000 in Q2 2026, compared with -$26,000 a year earlier.

Analysis

Quince Therapeutics, Inc. (QNCX) Change in Other Operating Liabilities (2025 - 2026) Analysis & Trends

On a TTM basis, IRulya Therapeutics' Change in Other Operating Liabilities came in at -$14,000 as of Jun 30, 2026; for FY2025, it came in at $742,000, up 580.7% from FY2024.

  • Across earlier years, Change in Other Operating Liabilities came in at $109,000 in FY2024.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -688,000.00
Mar 31, 2026 701,000.00
Jun 30, 2025 -26,000.00
Mar 31, 2025 -1,000.00
API Access

Quince Therapeutics, Inc. Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=QNCX&period=max&api_key=YOUR_API_KEY